This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cui, H. Articles by Ding, H.-F. Search for Related Content PubMed PubMed Citation Articles by Cui, H. Articles by Ding, H.-F.

Department of Biochemistry and Molecular Biology, Medical College of Ohio, Toledo, Ohio 43614

The signaling pathway for DNA damaging drug-triggered apoptosis was examined in a chemosensitive human neuroblastoma cell line, SH-SY5Y. Doxorubicin and etoposide induce rapid and extensive apoptosis in SH-SY5Y cells. After the drug treatment, p53 protein levels increase in the nucleus, leading to the induction of its transcription targets p21^Waf1/Cip1 and MDM2. Inactivation of p53, either by the human papillomavirus type 16 E6 protein or by a dominant-negative mutant p53 (R175H), completely protects SH-SY5Y cells from drug-triggered apoptosis. Cytochrome c and caspase-9 function downstream of p53 in mediating the drug-triggered apoptosis in SH-SY5Y cells. In drug-treated cells, cytochrome c is released, and caspase-9 becomes activated. Inactivation of p53 blocks cytochrome c release and caspase-9 activation. Furthermore, drug-induced cell death can be prevented by expression of a dominant-negative mutant of caspase-9. These findings define a molecular pathway for mediating DNA damaging drug-induced apoptosis in the human neuroblastoma SH-SY5Y cells and suggest that inactivation of essential components of this apoptotic pathway may confer drug resistance on neuroblastoma cells.

This article has been cited by other articles:

				B. Zhang, Z. Wang, T. Li, E. N. Tsitsikov, and H.-F. Ding NF-{kappa}B2 mutation targets TRAF1 to induce lymphomagenesis Blood, July 15, 2007; 110(2): 743 - 751. [Abstract] [Full Text] [PDF]

				H. Cui, B. Hu, T. Li, J. Ma, G. Alam, W. T. Gunning, and H.-F. Ding Bmi-1 Is Essential for the Tumorigenicity of Neuroblastoma Cells Am. J. Pathol., April 1, 2007; 170(4): 1370 - 1378. [Abstract] [Full Text] [PDF]

				I. Marzi, M. D'Amico, T. Biagiotti, S. Giunti, M. V. Carbone, D. Fredducci, E. Wanke, and M. Olivotto Purging of the Neuroblastoma Stem Cell Compartment and Tumor Regression on Exposure to Hypoxia or Cytotoxic Treatment Cancer Res., March 15, 2007; 67(6): 2402 - 2407. [Abstract] [Full Text] [PDF]

				H. Cui, J. Ma, J. Ding, T. Li, G. Alam, and H.-F. Ding Bmi-1 Regulates the Differentiation and Clonogenic Self-renewal of I-type Neuroblastoma Cells in a Concentration-dependent Manner J. Biol. Chem., November 10, 2006; 281(45): 34696 - 34704. [Abstract] [Full Text] [PDF]

				T. L'Ecuyer, S. Sanjeev, R. Thomas, R. Novak, L. Das, W. Campbell, and R. V. Heide DNA damage is an early event in doxorubicin-induced cardiac myocyte death Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1273 - H1280. [Abstract] [Full Text] [PDF]

				J.-F. Lavoie, L. LeSauteur, J. Kohn, J. Wong, O. Furtoss, C. J. Thiele, F. D. Miller, and D. R. Kaplan TrkA Induces Apoptosis of Neuroblastoma Cells and Does So via a p53-dependent Mechanism J. Biol. Chem., August 12, 2005; 280(32): 29199 - 29207. [Abstract] [Full Text] [PDF]

				M. Ogawa, H. Hori, T. Ohta, K. Onozato, M. Miyahara, and Y. Komada Sensitivity to Gemcitabine and Its Metabolizing Enzymes in Neuroblastoma Clin. Cancer Res., May 1, 2005; 11(9): 3485 - 3493. [Abstract] [Full Text] [PDF]

				H. Cui, T. Li, and H.-F. Ding Linking of N-Myc to Death Receptor Machinery in Neuroblastoma Cells J. Biol. Chem., March 11, 2005; 280(10): 9474 - 9481. [Abstract] [Full Text] [PDF]

				R. Torkin, J.-F. Lavoie, D. R. Kaplan, and H. Yeger Induction of caspase-dependent, p53-mediated apoptosis by apigenin in human neuroblastoma Mol. Cancer Ther., January 1, 2005; 4(1): 1 - 11. [Abstract] [Full Text] [PDF]